Sound Pharma to present positive interim data from its Phase 2b Cystic Fibrosis STOP Ototoxicity Trial

SEATTLE, Jan. 30, 2024 /PRNewswire/ — Sound Pharmaceuticals (SPI) will present the Phase 2b STOP Ototoxicity data that was selected for podium presentation at the Association for Research in Otolaryngology (ARO) Midwinter Meeting in Anaheim, CA (February 3-7). This initial safety and…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks